Francois Brisebois' Stock Ratings

Oppenheimer Analyst

Francois Brisebois is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/21/2024

Overall Average Return

-1.54%

Smart Score

Overall Average Return Percentile

33rd

Number of Ratings

95

Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

Expert Ratings For Praxis Precision Medicine

Beyond The Numbers: 4 Analysts Discuss Entrada Therapeutics Stock

Forecasting The Future: 14 Analyst Projections For Praxis Precision Medicine

These Analysts Increase Their Forecasts On Praxis Precision Medicines After Q2 Results

What 6 Analyst Ratings Have To Say About Praxis Precision Medicine

Forecasting The Future: 4 Analyst Projections For Simulations Plus

Netflix To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Thursday

Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing

Regarding Hertz, Jim Cramer said, "I don't want you to sell, and I don't want you to double down. Let's just see if it can't go higher."

Analyst Ratings For Tarsus Pharmaceuticals

Avadel Pharmaceuticals Analysts Increase Their Forecasts After Q4 Results

Avadel Pharmaceuticals plc (NASDAQ: AVDL) reported better-than-expected fourth-quarter revenue results and also issued a corporate update on Monday.

The Best Trading Research Platform

For Retail Investors and Professional Trades Alike.

Get Started for Free

Benzinga Pro on Macbook